Bispecific antibody's commercial premium within the mAb landscape — the engineered antibody formats that simultaneously engage two distinct epitopes or antigens — enabling immune cell redirection toward tumors through CD3xTumor Antigen bispecific T cell engagers, dual pathway blockade for inflammatory disease through bispecific checkpoint inhibitors, and improved receptor...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek